SCHEMBL19655565

SCHEMBL19655565

CCCOc1ccccc1N(C)C=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
HTT P42858 2/20 0.42
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
TDP1 Q9NUW8 3/20 0.41
MAPT P10636 2/20 0.40
LMNA P02545 1/20 0.40
PKM P14618 1/20 0.40
NLRP1 Q9C000 1/20 0.40
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
HTR1D P28221 1/20 0.38
HTR1B P28222 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6934541 0.89 LMNA (0.49) ALDH1A1TDP1MAPTLMNACYP1A2
SCHEMBL19418061 0.86 ALDH1A1 (0.44) ALDH1A1TDP1MAPTLMNACYP1A2
SCHEMBL22736940 0.83 CYP1A2 (0.39) ALDH1A1HTTTDP1MAPTLMNA
SCHEMBL19980436 0.81 HTR2C (0.41) ALDH1A1HTTHPGDMAPTMEN1
SCHEMBL15966175 0.80 CYP1A2 (0.44) TDP1MAPTCYP1A2CYP2C9CYP2C19
SCHEMBL21500739 0.80 GRM5 (0.40) ALDH1A1HTTHPGDSMN1; SMN2MAPT
SCHEMBL22048701 0.78 KMT2A (0.47) ALDH1A1HPGDSMN1; SMN2MAPTPKM
SCHEMBL19980139 0.78 CSNK2A1 (0.40) ALDH1A1HTTHPGDSMN1; SMN2MAPT
SCHEMBL7827917 0.77 CA1 (0.46) ALDH1A1HTTTDP1L3MBTL1GAA
SCHEMBL21156315 0.76 ALDH1A1 (0.35) ALDH1A1HTTHPGDTDP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3781571-B1 N-[4-OXO-2,3-DIHYDRO-PYRIDO[3,2-B][1,4]OXAZEPIN-3-YL]-5,6-DIHYDRO-4H-PYRROLO[1,2-B]PYRAZOLE-2-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS RIP1 KINASE INHIBITORS FOR TREATING E.G. IRRITABLE BOWEL SYNDROME (IBS) HOFFMANN LA ROCHE (CH) 2024-01-17 EP disclosed
WO-2021046382-A1 RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME RIGEL PHARMACEUTICALS, INC. (US) 2021-03-11 WO disclosed
EP-3760625-A1 BICYCLIC LACTAMS AS RECEPTOR-INTERACTING PROTEIN-1 (RIP1) KINASE INHIBITORS FOR TREATING E.G. INFLAMMATORY DISEASES F. Hoffmann-La Roche AG (CH) 2021-01-06 EP disclosed
EP-3342771-B1 HETEROCYCLIC AMIDES AS KINASE INHIBITORS GLAXOSMITHKLINE IP DEV LTD (GB) 2020-11-25 EP disclosed
EP-3375780-B1 HETEROCYCLIC AMIDES AS KINASE INHIBITORS GLAXOSMITHKLINE IP DEV LTD (GB) 2020-06-03 EP disclosed
WO-2019204537-A1 N-[4-OXO-2,3-DIHYDRO-1,5-BENZOXAZEPIN-3-YL]-5,6-DIHYDRO-4H-PYRROLO[1,2-B]PYRAZOL E-2-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS RIP1 KINASE INHIBITORS FOR TREATING E.G. IRRITABLE BOWEL SYNDROME (IBS) GENENTECH, INC. (US) 2019-10-24 WO disclosed
EP-3508484-A1 HETEROCYCLIC AMIDES AS KINASE INHIBITORS GlaxoSmithKline Intellectual Property Development Limited (GB) 2019-07-10 EP disclosed
EP-3342771-A1 HETEROCYCLIC AMIDES AS KINASE INHIBITORS GlaxoSmithKline Intellectual Property Development Ltd (GB) 2018-07-04 EP disclosed
WO-2018109097-A1 INHIBITORS OF RIP1 KINASE AND METHODS OF USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2018-06-21 WO disclosed
EP-2956452-B1 HETEROCYCLIC AMIDES AS KINASE INHIBITORS GLAXOSMITHKLINE IP DEV LTD (GB) 2018-03-21 EP disclosed
WO-2017004500-A9 BICYCLIC LACTAMS AND METHODS OF USE THEREOF GENENTECH, INC. (US) 2017-11-30 WO disclosed